시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 일회용 크로마토그래피 막 시장 보고서(2025년)
Single-Use Chromatography Membrane Global Market Report 2025
상품코드 : 1877885
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 일회용 크로마토그래피 막 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 11억 4,000만 달러에서 2025년에는 13억 2,000만 달러로, CAGR 15.9%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 바이오 의약품 생산 능력의 확대, 단클론항체에 대한 수요 증가, 바이오프로세스 조작의 중요성 증가, 지속 가능한 제조 방법에 대한 주목 증가, 생물학적 제제 및 백신에 대한 수요 급증으로 인한 것으로 예측됩니다.

일회용 크로마토그래피 막 시장 규모는 앞으로 수년간 급속한 성장이 예상됩니다. 2029년까지 23억 4,000만 달러에 달하고, CAGR은 15.5%가 될 전망입니다. 예측기간의 성장요인으로는 맞춤형 의료에 대한 수요 증가, 일회용 플랫폼 채용 확대, 생물학적 제제 제조 능력에 대한 투자 증가, 위탁개발제조기관(CDMO) 확대, 일회용 시스템에 대한 규제면 지원 강화 등을 들 수 있습니다. 예측 기간 동안 예상되는 주요 동향은 막 표면 화학 기술의 발전, 혼합 모드 막 흡착제의 혁신, 확장성 및 모듈성을 갖춘 일회용 플랫폼 개발, 리간드 설계 및 친화성 막의 연구 개발, 공정 분석 기술 및 자동화의 통합을 포함합니다.

맞춤형 의료의 보급 확대는 향후 수년간 일회용 크로마토그래피 막 시장의 성장을 이끌 것으로 예측됩니다. 맞춤형 의료란 보다 정확하고 효과적인 치료를 실현하기 위해 개인의 유전적, 분자적, 임상적 특성에 맞게 의료를 조정하는 것입니다. 개인화된 의료의 상승은 환자의 유전자 프로파일에 맞춤화된 치료법의 개발을 가능하게 하는 유전체학의 진보로 인해 효과와 안전성을 향상시킵니다. 일회용 크로마토그래피 멤브레인은 맞춤형 세포 요법 및 유전자 치료와 같은 환자 고유의 생체 의약품을 신속하고 유연하며 오염 없는 상태로 정제할 수 있게 함으로써 맞춤형 의료를 지원합니다. 이것은 개인화된 치료의 효율성과 안전성을 향상시킵니다. 예를 들어 미국 비영리 단체인 '맞춤형 의료연합'에 따르면 2024년 2월 시점에서 FDA는 2023년 희소질환 환자를 위한 신규 맞춤형 치료 16건을 승인했습니다. 이는 2022년 6건에서 증가하고 있습니다. 새롭게 승인된 치료에는 암 치료제 7건과 기타 질환 및 증상용 3건도 포함되어 있었습니다. 이와 같이 맞춤형 의료의 보급 확대가 일회용 크로마토그래피 막 시장의 성장에 기여하고 있습니다.

일회용 크로마토그래피 막 시장의 주요 기업은 공정 효율, 제품 수율 및 치료 품질을 향상시키기 위해 mRNA 정제와 같은 첨단 기술 개발에 주력하고 있습니다. mRNA 정제란 세포 성분과 반응 생성물의 혼합물로부터 메신저 RNA(mRNA) 분자를 분리하여 치료, 백신, 연구 용도에 적합한 고순도 mRNA를 얻는 기술입니다. 예를 들어, 2024년 12월에는 미국에 본사를 둔 생명과학 기업인 Repligen Corporation이 바이오 의약품 제조에 있어서의 dsRNA 정제를 간소화 및 가속하는 「AVIPure dsRNA Clear OPUS Columns」를 도입했습니다. 이 기술은 mRNA 치료제에서 이중 가닥 RNA 불순물을 불과 1분 안에 제거하는 빠르고 효율적인 방법을 제공하여 약물의 순도 향상과 면역 반응을 최소화합니다. 이 일회용 사전 포장 크로마토그래피 시스템은 가열 및 용매가 필요 없으며 워크플로우를 간소화하고 확장 가능한 생산을 지원합니다. 바이오 제조 공정에 원활한 통합을 통해 고품질, 안전하고 비용 효율적인 mRNA 백신 및 치료제를 확보하는 데 중요한 역할을합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

JHS
영문 목차

영문목차

A single-use chromatography membrane is a disposable filtration device utilized in bioprocessing and laboratory applications for the efficient separation and purification of biomolecules. Unlike conventional reusable chromatography columns, these membranes are intended for one-time use, removing the need for cleaning or sterilization, minimizing the risk of contamination, and enhancing process efficiency.

The main product types of single-use chromatography membranes include membrane adsorbers, capsules or cartridges, filter plates, and others. Membrane adsorbers are porous membranes that are functionalized with specific ligands, enabling selective adsorption and rapid purification of biomolecules in bioprocessing operations. The primary techniques employed include ion exchange, affinity, hydrophobic interaction, and others. These membranes are extensively used in applications such as biopharmaceutical production, vaccine manufacturing, and research and development, serving end-users such as pharmaceutical and biotechnology companies, academic institutions, and research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The single-use chromatography membrane market research report is one of a series of new reports from The Business Research Company that provides single-use chromatography membrane market statistics, including single-use chromatography membrane industry global market size, regional shares, competitors with a single-use chromatography membrane market share, detailed single-use chromatography membrane market segments, market trends and opportunities, and any further data you may need to thrive in the single-use chromatography membrane industry. This single-use chromatography membrane market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The single-use chromatography membrane market size has grown rapidly in recent years. It will grow from $1.14 billion in 2024 to $1.32 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to the expansion of biopharmaceutical production capacity, rising demand for monoclonal antibodies, increasing importance of bioprocessing operations, growing emphasis on sustainable manufacturing practices, and the escalating demand for biologics and vaccines.

The single-use chromatography membrane market size is expected to see rapid growth in the next few years. It will grow to $2.34 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to the increasing demand for personalized medicine, growing adoption of single-use platforms, rising investments in biologics manufacturing capacity, expansion of contract development and manufacturing organizations, and increasing regulatory support for single-use systems. Major trends expected during the forecast period include technological advancements in membrane surface chemistries, innovations in mixed-mode membrane adsorbers, developments in scalable and modular single-use platforms, research and development in ligand design and affinity membranes, and the integration of process analytical technology and automation.

The increasing adoption of personalized medicine is expected to drive the growth of the single-use chromatography membrane market in the coming years. Personalized medicine involves tailoring medical treatment to an individual's genetic, molecular, and clinical characteristics for more accurate and effective care. The rise in personalized medicine is attributed to advancements in genomics that enable the development of therapies customized to a patient's genetic profile, resulting in improved efficacy and safety. Single-use chromatography membranes support personalized medicine by providing faster, flexible, and contamination-free purification of patient-specific biologics, such as customized cell or gene therapies, thereby enhancing the efficiency and safety of individualized treatments. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized therapies for rare disease patients in 2023, up from six in 2022. These newly approved treatments also included seven cancer drugs and three for other diseases and conditions. Hence, the growing prevalence of personalized medicine is contributing to the expansion of the single-use chromatography membrane market.

Major companies in the single-use chromatography membrane market are focusing on developing advanced technologies, such as mRNA purification, to improve process efficiency, product yield, and therapeutic quality. mRNA purification involves isolating messenger RNA (mRNA) molecules from mixtures of cellular components or reaction products to obtain high-purity mRNA suitable for therapeutic, vaccine, or research applications. For instance, in December 2024, Repligen Corporation, a US-based life sciences company, introduced AVIPure dsRNA Clear OPUS Columns to simplify and accelerate dsRNA purification for biopharmaceutical manufacturing. This technology provides a rapid and efficient method to eliminate double-stranded RNA impurities from mRNA therapeutics in just one minute, improving drug purity and minimizing immune responses. The single-use, pre-packed chromatography system removes the need for heat or solvents, streamlines workflows, and supports scalable production. It plays a vital role in ensuring high-quality, safe, and cost-effective mRNA vaccines and therapeutics through seamless integration into biomanufacturing operations.

In February 2023, Biotage AB, a Sweden-based life sciences company, acquired Astrea Bioseparations Ltd. for an undisclosed amount. The acquisition aimed to strengthen Biotage's chromatography portfolio within the expanding bioprocessing sector, broaden its capabilities in biologics and advanced therapeutics, and position the company as a global leader in chromatography solutions with an enhanced pipeline and stronger financial foundation. Astrea Bioseparations Ltd. is a UK-based biotechnology company specializing in single-use chromatography membranes.

Major players in the single-use chromatography membrane market are Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, Solventum, Cytiva Life Sciences, W. L. Gore and Associates GORE Membrane Technologies, Sartorius Aktiengesellschaft, AGC Biologics GmbH, Repligen Corporation, GVS Group, i3 Membrane Inc., Cole-Parmer Instrument Company LLC, Restek Corporation, Cobetter Filtration Equipment Company Limited, Membrane Solutions LLC, Izon Science Limited, Sartorius Stedim Biotech S.A., BIA Separations Inc., NATRIX Separations Inc., and Purilogics.

North America was the largest region in the single-use chromatography membrane market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in single-use chromatography membrane report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the single-use chromatography membrane market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The single-use chromatography membrane market consists of sales of single-use membrane systems, pre-assembled systems, and specialty membrane modules. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Single-Use Chromatography Membrane Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on single-use chromatography membrane market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for single-use chromatography membrane ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The single-use chromatography membrane market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Single-Use Chromatography Membrane Market Characteristics

3. Single-Use Chromatography Membrane Market Trends And Strategies

4. Single-Use Chromatography Membrane Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Single-Use Chromatography Membrane Growth Analysis And Strategic Analysis Framework

6. Single-Use Chromatography Membrane Market Segmentation

7. Single-Use Chromatography Membrane Market Regional And Country Analysis

8. Asia-Pacific Single-Use Chromatography Membrane Market

9. China Single-Use Chromatography Membrane Market

10. India Single-Use Chromatography Membrane Market

11. Japan Single-Use Chromatography Membrane Market

12. Australia Single-Use Chromatography Membrane Market

13. Indonesia Single-Use Chromatography Membrane Market

14. South Korea Single-Use Chromatography Membrane Market

15. Western Europe Single-Use Chromatography Membrane Market

16. UK Single-Use Chromatography Membrane Market

17. Germany Single-Use Chromatography Membrane Market

18. France Single-Use Chromatography Membrane Market

19. Italy Single-Use Chromatography Membrane Market

20. Spain Single-Use Chromatography Membrane Market

21. Eastern Europe Single-Use Chromatography Membrane Market

22. Russia Single-Use Chromatography Membrane Market

23. North America Single-Use Chromatography Membrane Market

24. USA Single-Use Chromatography Membrane Market

25. Canada Single-Use Chromatography Membrane Market

26. South America Single-Use Chromatography Membrane Market

27. Brazil Single-Use Chromatography Membrane Market

28. Middle East Single-Use Chromatography Membrane Market

29. Africa Single-Use Chromatography Membrane Market

30. Single-Use Chromatography Membrane Market Competitive Landscape And Company Profiles

31. Single-Use Chromatography Membrane Market Other Major And Innovative Companies

32. Global Single-Use Chromatography Membrane Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Single-Use Chromatography Membrane Market

34. Recent Developments In The Single-Use Chromatography Membrane Market

35. Single-Use Chromatography Membrane Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기